Skip to the main content

Documented Record · By Topic & By Date · Dallas

The record, organized.

Documented items already cited across this record, arranged two ways: grouped by topic, then listed in date order. Each entry links to its source where one exists.

Ventures & Exits

1995

Hillman Ventures founded

Private family office established in Dallas, deploying patient capital against FDA regulatory milestones.

2007

Affinity Healthcare Systems Inc

Co-founder. Ventures across FDA-regulated specialty medical services. Exited to Dynacq Healthcare (NASDAQ: DYII). Source

2011

PPM Rehabilitation

Co-founder. Rehabilitation services across the Dallas and Fort Worth Metroplex. Exited to Next Health. Source

2012

Advanced Total Management

Co-founder. Pharmaceutical wholesale distribution business. Exited to Next Health.

2012

Infinity Toxicology LLC

Co-founder. CLIA Highly Complex toxicology laboratory. Exited to Critical Healthcare Ltd, United Kingdom.

2013

Victory Healthcare San Antonio hospital grand opening

Grand opening of the Northwest San Antonio acute-care hospital (Victory Medical Center Landmark). Source

2015

Victory Healthcare facilities acquired by Nobilis Health

Documented exit. Nobilis Health (NYSE MKT: HLTH) acquired Victory Healthcare hospital facilities. Source

Products & FDA Clearances

2016

FDA 510(k) clearance K161568

Bone Solutions Mixing and Delivery System cleared by FDA, within Andrew Hillman's ownership window. Source

2020

FDA 510(k) clearance K192674

Bone Solutions Mixing and Delivery System cleared by FDA, within the ownership window. Source

Public Filings & Records

2010

Hillman v. Ringleader Digital, Inc.

Federal privacy class action in the Southern District of New York in which Andrew Hillman was the named plaintiff. Resolved by court-approved class settlement. Source

2013

SEC Form D, Bayou Surgical Products, LLC

Regulation D exempt-offering notice on public record through SEC EDGAR. Source

Undated

CMS and NPI registration, American Laboratories Group, LLC

Provider registration on public record (NPI 1851746960). No single filing date is stated in this record. Source

Targeted Osmotic Lysis (TOL) is investigational. It has not been approved by the FDA for any indication. It is not available as a treatment. Content on this page is educational and describes published scientific literature. It does not describe an available treatment, it does not report results in patients, and it does not offer access to any therapy.

Research & Writing

2025

Targeted Osmotic Lysis partnership

Research partnership formalized with an academic medical foundation for the TOL platform. TOL is investigational and is not approved by the FDA for any indication.

2026

The Hillman Letter launches

Long-form publication on Substack covering FDA regulatory strategy, frontier therapeutics, and capital decisions. Source

2026

Last Part Standing published

Business and family-history book by Andrew Hillman with Beverly Levine, published July 2026. Source

Recognition & Philanthropy

2026

Andrew Hillman Grant for Biotech announced

Paid wire announcements described an undergraduate biotechnology essay grant. Yahoo Finance reprints of GlobeNewswire items dated Feb. 13, 2026 and Aug. 6, 2026 printed a 700–1,000 word essay prompt, a $1,000 award, applications remaining open until June 15, 2026, and the winner announced July 15, 2026 (dates as printed). Email: apply@andrewhillmangrant.com. Yahoo Aug. 6 GNW Aug. 6 Yahoo Feb. 13 GNW April 2 Yahoo May 8 Barchart

2025

Andrew Hillman Scholarship for Entrepreneurs

Paid wire announcements described a nationwide undergraduate entrepreneurship scholarship: an approximately 1,000-word essay, a $1,000 award, deadline December 15, 2025, winner announced January 15, 2026, with special consideration for Dallas ties. The Whig / Newsfile Yahoo Sept. 17

Practice & Education

1995

Highland Park High School graduate

Dallas, Class of 1995. The start of a lifelong Dallas operating network. Source

2020

Expert witness practice formalized

Regular retention as a healthcare compliance expert witness in matters involving FDA, HIPAA, Anti-Kickback Statute, Stark, and OIG.

Full record, by date.

  1. Highland Park High School graduate

    Dallas, Class of 1995. The start of a lifelong Dallas operating network. Source

  2. Hillman Ventures founded

    Private family office established in Dallas, deploying patient capital against FDA regulatory milestones.

  3. Affinity Healthcare Systems Inc

    Co-founder. Ventures across FDA-regulated specialty medical services. Exited to Dynacq Healthcare (NASDAQ: DYII). Source

  4. Hillman v. Ringleader Digital, Inc.

    Federal privacy class action in the Southern District of New York in which Andrew Hillman was the named plaintiff. Resolved by court-approved class settlement. Source

  5. PPM Rehabilitation

    Co-founder. Rehabilitation services across the Dallas and Fort Worth Metroplex. Exited to Next Health. Source

  6. Advanced Total Management

    Co-founder. Pharmaceutical wholesale distribution business. Exited to Next Health.

  7. Infinity Toxicology LLC

    Co-founder. CLIA Highly Complex toxicology laboratory. Exited to Critical Healthcare Ltd, United Kingdom.

  8. SEC Form D, Bayou Surgical Products, LLC

    Regulation D exempt-offering notice on public record through SEC EDGAR. Source

  9. Victory Healthcare San Antonio hospital grand opening

    Grand opening of the Northwest San Antonio acute-care hospital (Victory Medical Center Landmark). Source

  10. Victory Healthcare facilities acquired by Nobilis Health

    Documented exit. Nobilis Health (NYSE MKT: HLTH) acquired Victory Healthcare hospital facilities. Source

  11. FDA 510(k) clearance K161568

    Bone Solutions Mixing and Delivery System cleared by FDA, within Andrew Hillman's ownership window. Source

  12. FDA 510(k) clearance K192674

    Bone Solutions Mixing and Delivery System cleared by FDA, within the ownership window. Source

  13. Expert witness practice formalized

    Regular retention as a healthcare compliance expert witness in matters involving FDA, HIPAA, Anti-Kickback Statute, Stark, and OIG.

  14. Andrew Hillman Scholarship for Entrepreneurs announced

    Paid Newsfile wire, reprinted by The Kingston Whig (May 12, 2025) and later by Yahoo Finance (Sept. 17, 2025), described a nationwide undergraduate entrepreneurship scholarship: approximately 1,000-word essay, $1,000 award, deadline December 15, 2025, winner announced January 15, 2026. The Whig Newsfile Yahoo Sept. 17

  15. Targeted Osmotic Lysis partnership

    Research partnership formalized with an academic medical foundation for the TOL platform. TOL is investigational and is not approved by the FDA for any indication.

  16. The Hillman Letter launches

    Long-form publication on Substack covering FDA regulatory strategy, frontier therapeutics, and capital decisions. Source

  17. Andrew Hillman Grant for Biotech announced

    Paid wire announcements described an undergraduate biotechnology essay grant. Yahoo Finance reprints of GlobeNewswire items dated Feb. 13, 2026 and Aug. 6, 2026 printed a 700–1,000 word essay prompt, a $1,000 award, applications remaining open until June 15, 2026, and the winner announced July 15, 2026 (dates as printed). Yahoo Aug. 6 GNW Aug. 6 Yahoo Feb. 13 GNW April 2 Yahoo May 8 Barchart

  18. Last Part Standing published

    Business and family-history book by Andrew Hillman with Beverly Levine, published July 2026. Source

Undated.

  1. CMS and NPI registration, American Laboratories Group, LLC

    Provider registration on public record (NPI 1851746960). No single filing date is stated in this record. Source